Impact of Prophylactic Corticosteroid Use on In-hospital Mortality and Respiratory Failure After Esophagectomy for Esophageal Cancer

Objective: To assess the effect of preoperative prophylactic corticosteroid use on short-term outcomes after oncologic esophagectomy. Background: Previous studies have shown that prophylactic corticosteroid use may decrease the risk of respiratory failure following esophagectomy by attenuating the perioperative systemic inflammation response. However, its effectiveness has been controversial, and its impact on mortality remains unknown. Methods: Data of patients who underwent oncologic esophagectomy between July 2010 and March 2019 were extracted from a Japanese nationwide inpatient database. Stabilized inverse probability of treatment weighting, propensity score matching, and instrumental variable analyses were performed to investigate the associations between prophylactic corticosteroid use and short-term outcomes, such as in-hospital mortality and respiratory failure, adjusting for potential confounders. Results: Among 35,501 eligible patients, prophylactic corticosteroids were used in 22,620 (63.7%) patients. In-hospital mortality, respiratory failure, and severe respiratory failure occurred in 924 (2.6%), 5440 (15.3%), and 2861 (8.1%) patients, respectively. In stabilized inverse probability of treatment weighting analyses, corticosteroids were significantly associated with decreased in-hospital mortality [odds ratio (OR)=0.80; 95% confidence interval (CI): 0.69–0.93], respiratory failure (OR=0.84; 95% CI: 0.79–0.90), and severe respiratory failure (OR=0.87; 95% CI: 0.80–0.95). Corticosteroids were also associated with decreased postoperative length of stay and total hospitalization costs. The proportion of anastomotic leakage did not differ with the use of Propensity score matching and instrumental variable analysis demonstrated similar results. Conclusions: Prophylactic corticosteroid use in oncologic esophagectomy was associated with lower in-hospital mortality as well as decreased respiratory failure and severe respiratory failure, suggesting a potential benefit for preoperative corticosteroid use in esophagectomy.

[1]  H. Yasunaga,et al.  Validity of initial cancer diagnoses in the Diagnosis Procedure Combination data in Japan. , 2021, Cancer epidemiology.

[2]  H. Shinozaki,et al.  Pharmacological treatment to reduce pulmonary morbidity after esophagectomy , 2021, Annals of gastroenterological surgery.

[3]  S. Jaber,et al.  Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery: multicentre, double blind, randomised controlled trial , 2021, BMJ.

[4]  A. Zarbock,et al.  Systemic Inflammatory Response Syndrome After Surgery: Mechanisms and Protection , 2020, Anesthesia and analgesia.

[5]  O. Dekkers,et al.  The efficacy and safety of prophylactic corticosteroids for the prevention of adverse outcomes in patients undergoing heart surgery using cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials. , 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  Jessica M Franklin,et al.  Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners , 2019, BMJ.

[7]  H. Shinozaki,et al.  Administration of Corticosteroids, Ascorbic Acid, and Thiamine Improves Oxygenation after Thoracoscopic Esophagectomy , 2019, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[8]  B. Beck-Schimmer,et al.  Cytokine Response in the Pleural Fluid and Blood in Minimally Invasive and Open Esophagectomy , 2019, World Journal of Surgery.

[9]  E. Goldmuntz,et al.  2-Year Outcomes After Complete or Staged Procedure for Tetralogy of Fallot in Neonates. , 2019, Journal of the American College of Cardiology.

[10]  R. Engelman,et al.  Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery Society Recommendations. , 2019, JAMA surgery.

[11]  H. Yasunaga,et al.  Comparing Perioperative Mortality and Morbidity of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer , 2019, Annals of surgery.

[12]  O. Ljungqvist,et al.  Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations , 2018, World Journal of Surgery.

[13]  Masahiro Yoshida,et al.  Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2 , 2018, Esophagus.

[14]  Kazuhiro Yoshida,et al.  Immediate extubation after esophagectomy with three-field lymphadenectomy enables early ambulation in patients with thoracic esophageal cancer , 2018, Esophagus.

[15]  A. Chang,et al.  Benchmarking Complications Associated with Esophagectomy , 2017, Annals of surgery.

[16]  G. Rücker,et al.  Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. , 2017, The Cochrane database of systematic reviews.

[17]  K. Moorthy,et al.  Component analysis of enhanced recovery pathways for esophagectomy. , 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[18]  H. Horiguchi,et al.  Validity of diagnoses, procedures, and laboratory data in Japanese administrative data , 2017, Journal of epidemiology.

[19]  François Alla,et al.  The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality , 2016, Medical care.

[20]  S. Yusuf,et al.  Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial , 2015, The Lancet.

[21]  R. van Hillegersberg,et al.  The effect of perioperative administration of glucocorticoids on pulmonary complications after transthoracic oesophagectomy: A systematic review and meta-analysis , 2014, European journal of anaesthesiology.

[22]  Y. Doki,et al.  Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society , 2014, Esophagus.

[23]  R. Marshall,et al.  Enhanced Recovery for Esophagectomy: A Systematic Review and Evidence-Based Guidelines , 2014, Annals of surgery.

[24]  Long-Qi Chen,et al.  Effect of perioperative glucocorticoid administration on postoperative complications following esophagectomy: A meta-analysis , 2013, Oncology letters.

[25]  A. Kosinski,et al.  Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. , 2013, The Annals of thoracic surgery.

[26]  J. Tijssen,et al.  Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. , 2012, JAMA.

[27]  T. Yu,et al.  Preoperative Glucocorticoid Use in Major Abdominal Surgery: Systematic Review and Meta-Analysis of Randomized Trials , 2011, Annals of surgery.

[28]  Bing Li,et al.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. , 2011, American journal of epidemiology.

[29]  E. Engelman,et al.  Effect of Preoperative Single-Dose Corticosteroid Administration on Postoperative Morbidity Following Esophagectomy , 2010, Journal of Gastrointestinal Surgery.

[30]  E. Oki,et al.  Evaluation of the feasibility and safety of immediate extubation after esophagectomy with extended radical three-field lymph node dissection for thoracic esophageal cancers , 2009, Esophagus.

[31]  M. Raebel,et al.  Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[32]  Y. Nishimura,et al.  Guidelines for diagnosis and treatment of carcinoma of the esophagus , 2008, Esophagus.

[33]  H. Kuwano,et al.  Effect of perioperative steroid therapy on the postoperative course of patients with oesophageal cancer. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[34]  H. Quan,et al.  Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.

[35]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[36]  J. Hanley,et al.  Statistical analysis of correlated data using generalized estimating equations: an orientation. , 2003, American journal of epidemiology.

[37]  T. Iwaya,et al.  Randomized Study of the Benefits of Preoperative Corticosteroid Administration on the Postoperative Morbidity and Cytokine Response in Patients Undergoing Surgery for Esophageal Cancer , 2002, Annals of surgery.

[38]  M. Arima,et al.  Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. , 2000, Surgery.

[39]  H. Yasunaga,et al.  Introduction to Instrumental Variable Analysis , 2020, Annals of Clinical Epidemiology.

[40]  H. Yasunaga.  Introduction to Applied Statistics—Chapter 1 Propensity Score Analysis , 2020, Annals of Clinical Epidemiology.

[41]  Hideo Yasunaga,et al.  Real World Data in Japan: Chapter II The Diagnosis Procedure Combination Database , 2019, Annals of Clinical Epidemiology.